APA

Thomas M., Ponce-Aix S., Navarro A., Riera-Knorrenschild J., Schmidt M., Wiegert E., Kapp K., Wittig B., Mauri C., Dómine Gómez M., Kollmeier J., Sadjadian P., Fröhling K., Huber R. M. & Wolf M. (20191125). Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Thomas M, Ponce-Aix S, Navarro A, Riera-Knorrenschild J, Schmidt M, Wiegert E, Kapp K, Wittig B, Mauri C, Dómine Gómez M, Kollmeier J, Sadjadian P, Fröhling K-P, Huber R M and Wolf M. 20191125. Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Thomas M., Ponce-Aix S., Navarro A., Riera-Knorrenschild J., Schmidt M., Wiegert E., Kapp K., Wittig B., Mauri C., Dómine Gómez M., Kollmeier J., Sadjadian P., Fröhling K., Huber R. M. and Wolf M. (20191125). Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Thomas M, Ponce-Aix S, Navarro A, Riera-Knorrenschild J, Schmidt M, Wiegert E, Kapp K, Wittig B, Mauri C, Dómine Gómez M, Kollmeier J, Sadjadian P, Fröhling K-P, Huber R M and Wolf M. Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study. : Annals of oncology : official journal of the European Society for Medical Oncology. 20191125.